JANWX
Price
$126.01
Change
+$0.31 (+0.25%)
Updated
Aug 26 closing price
Net Assets
4.32B
NPFCX
Price
$66.37
Change
+$0.03 (+0.05%)
Updated
Aug 26 closing price
Net Assets
158.54B
Interact to see
Advertisement

JANWX vs NPFCX

Header iconJANWX vs NPFCX Comparison
Open Charts JANWX vs NPFCXBanner chart's image
Janus Henderson Global Research D
Price$126.01
Change+$0.31 (+0.25%)
VolumeN/A
Net Assets4.32B
American Funds New Perspective C
Price$66.37
Change+$0.03 (+0.05%)
VolumeN/A
Net Assets158.54B
JANWX vs NPFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JANWX vs. NPFCX commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANWX is a Buy and NPFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 159B vs. JANWX (4.32B). JANWX pays higher dividends than NPFCX: JANWX (0.66) vs NPFCX (0.00). JANWX was incepted earlier than NPFCX: JANWX (21 years) vs NPFCX (24 years). NPFCX (1.48) is less costly to investors than JANWX (0.75). JANWX is a more actively managed with annual turnover of: 28.00 vs. NPFCX (24.00). NPFCX has a lower initial minimum investment than JANWX: NPFCX (250) vs JANWX (2500). JANWX (11.17) and NPFCX (10.89) have marching annual gain over last year. JANWX return over 5 years is better than : 42.65 vs. NPFCX (26.38).
JANWXNPFCXJANWX / NPFCX
Total Expense Ratio0.751.4851%
Annual Report Gross Expense Ratio0.751.4851%
Fund Existence21 years24 years-
Gain YTD15.53314.629106%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.32B159B3%
Annual Yield % from dividends0.660.00-
Returns for 1 year11.1710.89103%
Returns for 3 years52.5239.15134%
Returns for 5 years42.6526.38162%
Returns for 10 years113.8085.43133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP1.140.05
+4.59%
GT Biopharma
BWB16.380.31
+1.93%
Bridgewater Bancshares
CCK100.790.59
+0.59%
Crown Holdings
NGVT56.990.12
+0.21%
Ingevity Corp
CATO3.95-0.11
-2.71%
CATO Corp